,reactionmeddraversionpt,reactionmeddrapt,safetyreportid,reactionoutcome
0,22.1,Disease progression,16781773,
0,22.1,Drug ineffective,16781776,6
0,22.1,Malignant neoplasm progression,16781784,5
1,22.1,Oedema,16781784,6
2,22.1,Platelet count decreased,16781784,6
3,22.1,Neutrophil count decreased,16781784,6
4,22.1,Anaemia,16781784,6
5,22.1,Fatigue,16781784,6
0,22.1,Memory impairment,16781795,
1,22.1,Paraesthesia,16781795,
2,22.1,Pain,16781795,
0,22.1,Disease progression,16781813,
0,22.0,Weight decreased,16781862,3
1,22.0,Dehydration,16781862,6
2,22.0,Food craving,16781862,3
3,22.0,Death,16781862,5
4,22.0,Diarrhoea,16781862,3
5,22.0,Pollakiuria,16781862,3
6,22.0,Dyspnoea,16781862,6
0,22.1,Death,16781871,
0,22.0,Death,16781901,5
0,22.1,Hot flush,16781944,
0,22.0,Product use in unapproved indication,16781945,6
1,22.0,Aspartate aminotransferase increased,16781945,6
0,22.1,Asthenia,16781950,6
1,22.1,Urinary bladder haemorrhage,16781950,1
0,22.0,Death,16781991,5
0,22.0,Malignant neoplasm progression,16782036,6
1,22.0,Female genital tract fistula,16782036,3
0,22.0,Diplopia,16782061,6
1,22.0,Hypokalaemia,16782061,6
2,22.0,Dysarthria,16782061,6
3,22.0,Dyspnoea,16782061,6
4,22.0,Tremor,16782061,6
0,22.0,Hot flush,16782068,6
1,22.0,Fatigue,16782068,6
0,22.0,Tonsil cancer,16782069,3
0,22.0,Pulmonary embolism,16782206,5
1,22.0,Cardiac failure,16782206,5
0,22.0,Neoplasm malignant,16782208,3
1,22.0,Drug ineffective,16782208,3
0,22.0,Hormone-refractory prostate cancer,16782371,6
1,22.0,Androgen deficiency,16782371,3
2,22.0,Metastases to liver,16782371,6
3,22.0,Hydronephrosis,16782371,6
0,22.0,Discomfort,16782412,6
1,22.0,Sleep disorder,16782412,6
2,22.0,Pain,16782412,3
3,22.0,Fatigue,16782412,3
4,22.0,Malignant neoplasm progression,16782412,3
5,22.0,Nausea,16782412,6
6,22.0,Nervous system disorder,16782412,3
7,22.0,Vomiting,16782412,6
0,22.0,Tumour marker increased,16782429,6
1,22.0,Asthenia,16782429,6
2,22.0,Nausea,16782429,3
3,22.0,Fatigue,16782429,6
4,22.0,Malaise,16782429,3
5,22.0,Intra-abdominal fluid collection,16782429,6
6,22.0,Constipation,16782429,6
7,22.0,Abdominal distension,16782429,3
8,22.0,Malignant neoplasm progression,16782429,6
9,22.0,Taste disorder,16782429,6
10,22.0,Decreased appetite,16782429,6
0,22.0,Diet refusal,16782442,2
1,22.0,Diarrhoea,16782442,2
0,22.0,Anaphylactic shock,16782461,6
0,22.1,Insomnia,16782476,6
1,22.1,Dental caries,16782476,6
2,22.1,Erythema,16782476,6
3,22.1,Pruritus,16782476,6
4,22.1,Dysphonia,16782476,2
5,22.1,Haemorrhoidal haemorrhage,16782476,6
6,22.1,Inappropriate antidiuretic hormone secretion,16782476,1
7,22.1,Hypertension,16782476,6
8,22.1,Fatigue,16782476,6
9,22.1,Urinary tract infection,16782476,6
10,22.1,Constipation,16782476,6
11,22.1,Onychoclasis,16782476,6
12,22.1,Oedema peripheral,16782476,2
13,22.1,Gastrointestinal haemorrhage,16782476,6
14,22.1,Dry mouth,16782476,6
15,22.1,Palmar-plantar erythrodysaesthesia syndrome,16782476,6
16,22.1,Pain in extremity,16782476,6
17,22.1,Blood sodium decreased,16782476,6
18,22.1,Diarrhoea,16782476,6
19,22.1,Faeces discoloured,16782476,6
20,22.1,Haematochezia,16782476,6
21,22.1,Headache,16782476,6
22,22.1,Cough,16782476,2
23,22.1,Eye pain,16782476,6
0,22.0,Underdose,16782482,6
1,22.0,Respiratory failure,16782482,6
2,22.0,Pneumonitis,16782482,1
0,22.1,Inappropriate antidiuretic hormone secretion,16782485,2
1,22.1,Interstitial lung disease,16782485,5
2,22.1,Hepatic cancer metastatic,16782485,5
3,22.1,Hypercapnia,16782485,6
4,22.1,Non-small cell lung cancer metastatic,16782485,5
5,22.1,Hyponatraemia,16782485,6
0,22.1,Diarrhoea,16782498,
1,22.1,Fatigue,16782498,
2,22.1,White blood cell count decreased,16782498,
0,22.0,Platelet count decreased,16782557,1
1,22.0,Anaemia,16782557,2
2,22.0,Nausea,16782557,1
3,22.0,Intestinal obstruction,16782557,2
4,22.0,Neutrophil count decreased,16782557,1
0,22.0,Malignant neoplasm progression,16782560,5
1,22.0,Drug resistance,16782560,6
2,22.0,Metastasis,16782560,6
0,22.0,Anaphylactic shock,16782570,6
0,22.0,Pyrexia,16782584,1
1,22.0,Chills,16782584,1
2,22.0,Nausea,16782584,1
3,22.0,Abdominal pain,16782584,1
0,22.0,Anxiety,16782609,6
1,22.0,Pain,16782609,6
2,22.0,Alopecia,16782609,2
3,22.0,Impaired quality of life,16782609,6
4,22.0,Emotional distress,16782609,6
0,22.0,Psychological trauma,16782615,6
1,22.0,Alopecia,16782615,2
0,22.0,Liver disorder,16782616,3
1,22.0,Malignant neoplasm progression,16782616,6
2,22.0,Adrenocorticotropic hormone deficiency,16782616,6
3,22.0,Adrenal insufficiency,16782616,1
0,22.0,Psychological trauma,16782621,6
1,22.0,Alopecia,16782621,3
0,22.0,Psychological trauma,16782623,6
1,22.0,Alopecia,16782623,2
0,22.0,Adverse event,16782721,6
0,22.0,Dysphagia,16782770,6
1,22.0,Cognitive disorder,16782770,6
2,22.0,Somnolence,16782770,6
3,22.0,Sleep apnoea syndrome,16782770,6
4,22.0,Decreased appetite,16782770,2
5,22.0,Anxiety,16782770,6
6,22.0,Insomnia,16782770,6
7,22.0,Constipation,16782770,6
8,22.0,Delirium,16782770,6
9,22.0,Depression,16782770,2
10,22.0,Urinary retention,16782770,6
11,22.0,Vomiting,16782770,6
12,22.0,Pulmonary embolism,16782770,6
13,22.0,Adverse event,16782770,6
14,22.0,Dyspnoea,16782770,6
15,22.0,Fatigue,16782770,6
0,22.0,Hyperglycaemia,16782800,2
0,22.0,Malignant neoplasm progression,16782841,5
1,22.0,Small cell lung cancer,16782841,5
2,22.0,Therapeutic response decreased,16782841,6
0,22.1,Fatigue,16782842,2
1,22.1,Paraesthesia,16782842,2
2,22.1,Amnesia,16782842,2
3,22.1,Diarrhoea,16782842,2
0,22.0,Interstitial lung disease,16782927,1
1,22.0,Pneumonia bacterial,16782927,6
0,22.1,General physical health deterioration,16782970,1
1,22.1,Pyrexia,16782970,1
0,22.0,Interstitial lung disease,16782989,2
0,22.0,Performance status decreased,16783029,6
1,22.0,Drug intolerance,16783029,6
2,22.0,Autoimmune myocarditis,16783029,4
3,22.0,Lymphadenopathy mediastinal,16783029,6
4,22.0,Ventricular tachycardia,16783029,6
5,22.0,Congestive cardiomyopathy,16783029,4
6,22.0,Left ventricular dysfunction,16783029,3
7,22.0,Inappropriate schedule of product administration,16783029,6
8,22.0,Pleural effusion,16783029,6
9,22.0,Cardiac failure chronic,16783029,6
10,22.0,Cardiac failure,16783029,6
0,22.1,Headache,16783039,6
1,22.1,Insulin resistant diabetes,16783039,2
2,22.1,Hyperkinesia,16783039,6
0,22.1,Skin ulcer,16783040,1
1,22.1,Acute kidney injury,16783040,1
2,22.1,Sepsis,16783040,1
3,22.1,Blood creatine phosphokinase increased,16783040,1
4,22.1,Monoparesis,16783040,2
0,22.0,Cholecystitis infective,16783041,6
0,22.0,Renal disorder,16783063,5
1,22.0,Urinary tract disorder,16783063,5
0,22.0,Neuropathy peripheral,16783078,6
1,22.0,Febrile neutropenia,16783078,6
0,22.0,Neutropenia,16783086,6
1,22.0,Pneumonia,16783086,6
2,22.0,Dyspnoea,16783086,6
0,22.0,Migraine with aura,16783196,3
0,22.0,Product use in unapproved indication,16783241,6
0,22.1,Chest pain,16783250,6
1,22.1,Dyspnoea,16783250,6
2,22.1,Pneumonitis chemical,16783250,6
0,22.0,Chest discomfort,16783263,6
1,22.0,Dyspnoea,16783263,6
2,22.0,Cough,16783263,6
3,22.0,Hypoxia,16783263,6
4,22.0,Flushing,16783263,6
5,22.0,Hypotension,16783263,6
0,22.0,Cardiac death,16783266,5
1,22.0,Fall,16783266,5
0,22.0,Blood glucose increased,16783302,1
1,22.0,Prostatomegaly,16783302,1
2,22.0,Hypotension,16783302,1
3,22.0,Gastrointestinal infection,16783302,1
4,22.0,Prostatic haemorrhage,16783302,1
5,22.0,Kidney infection,16783302,1
6,22.0,Product dose omission,16783302,1
0,22.0,Death,16783314,5
0,22.0,Hypoglycaemia,16783316,6
1,22.0,Dizziness,16783316,6
2,22.0,Off label use,16783316,6
0,22.0,Pneumonitis,16783318,5
0,22.0,Faeces pale,16783355,6
1,22.0,Fatigue,16783355,6
2,22.0,Chromaturia,16783355,6
3,22.0,Jaundice cholestatic,16783355,3
4,22.0,Liver injury,16783355,6
0,22.0,Sjogren^s syndrome,16783417,6
1,22.0,Vasculitic rash,16783417,6
2,22.0,Dry eye,16783417,2
0,22.0,Burning sensation,16783486,6
1,22.0,Mobility decreased,16783486,6
2,22.0,Arthralgia,16783486,6
0,22.0,Nausea,16783491,6
1,22.0,Pyrexia,16783491,6
2,22.0,Photosensitivity reaction,16783491,1
3,22.0,Intertrigo,16783491,1
0,22.0,Full blood count,16783519,5
1,22.0,Febrile neutropenia,16783519,5
2,22.0,Pneumonia,16783519,5
0,22.0,Drug interaction,16783551,6
1,22.0,Hypoglycaemia,16783551,1
0,22.0,Death,16783602,5
0,22.0,Hypoaesthesia,16783614,6
1,22.0,Nausea,16783614,6
2,22.0,Vomiting,16783614,6
3,22.0,Diarrhoea,16783614,6
4,22.0,Chills,16783614,6
0,22.1,Herpes zoster,16783615,5
1,22.1,Tumour pain,16783615,1
2,22.1,Pyrexia,16783615,1
3,22.1,Pain,16783615,1
4,22.1,Fall,16783615,1
0,22.1,Chest pain,16783637,6
1,22.1,Melaena,16783637,1
2,22.1,Dyspnoea,16783637,6
3,22.1,Haemoglobin decreased,16783637,6
4,22.1,White blood cell count decreased,16783637,6
5,22.1,Constipation,16783637,2
6,22.1,Platelet count decreased,16783637,6
7,22.1,Blood count abnormal,16783637,6
8,22.1,Blood pressure fluctuation,16783637,1
9,22.1,Dyspnoea exertional,16783637,3
0,22.1,Full blood count decreased,16783638,6
1,22.1,Underdose,16783638,6
2,22.1,Adverse drug reaction,16783638,6
0,22.0,Colony stimulating factor therapy,16783669,6
1,22.0,Febrile neutropenia,16783669,1
0,22.0,Dyschezia,16783692,1
0,22.1,Hypokalaemia,16783792,1
1,22.1,Gamma-glutamyltransferase increased,16783792,1
2,22.1,Sleep disorder,16783792,6
3,22.1,Thrombocytopenia,16783792,1
4,22.1,Nausea,16783792,3
5,22.1,Procedural pain,16783792,1
6,22.1,Blood creatinine increased,16783792,6
0,22.0,Melanocytic naevus,16783793,6
0,22.0,Drug intolerance,16783796,6
1,22.0,Metastases to lung,16783796,6
2,22.0,Metastases to bone,16783796,6
3,22.0,Alopecia,16783796,3
4,22.0,Metastases to liver,16783796,6
0,22.0,Hepatotoxicity,16783818,6
0,22.0,Anaphylactic reaction,16783828,6
0,22.1,Renal disorder,16783836,2
1,22.1,Blood creatinine increased,16783836,2
0,22.0,Death,16783973,5
0,22.1,Hypoglycaemia,16783993,6
1,22.1,Pyrexia,16783993,1
2,22.1,Blood glucose increased,16783993,6
3,22.1,Rash,16783993,6
4,22.1,Ketoacidosis,16783993,6
0,22.1,Fatigue,16784016,6
1,22.1,Off label use,16784016,6
2,22.1,Eczema,16784016,3
0,22.0,Chest pain,16784024,6
1,22.0,Dyspnoea,16784024,6
0,22.0,Death,16784113,5
0,22.0,Pulmonary function test decreased,16784150,6
1,22.0,Discomfort,16784150,6
2,22.0,Nasopharyngitis,16784150,2
3,22.0,Renal impairment,16784150,6
4,22.0,Renal impairment,16784150,6
5,22.0,Diarrhoea,16784150,6
0,22.0,Pancreatitis,16784167,6
0,22.0,Hepatitis acute,16784229,2
0,22.0,Ischaemic stroke,16784233,2
0,22.0,Adverse event,16784254,6
0,22.1,Hypokalaemia,16784269,1
1,22.1,Blood creatinine increased,16784269,6
2,22.1,Nausea,16784269,3
3,22.1,Procedural pain,16784269,1
4,22.1,Sleep disorder,16784269,6
5,22.1,Breast pain,16784269,6
6,22.1,Thrombocytopenia,16784269,1
7,22.1,Gamma-glutamyltransferase increased,16784269,1
0,22.0,Cardiac failure,16784274,5
0,22.0,Pain,16784291,6
0,22.0,Atrial fibrillation,16784411,1
0,22.0,Product use in unapproved indication,16784418,6
1,22.0,Therapy partial responder,16784418,6
0,22.0,Neoplasm malignant,16784455,5
0,22.0,Treatment failure,16784494,2
1,22.0,Salivary gland cancer,16784494,2
0,22.1,Stomatitis,16784515,1
0,22.0,Cough,16784529,6
1,22.0,Dysphagia,16784529,6
2,22.0,Constipation,16784529,6
3,22.0,Sleep disorder,16784529,6
4,22.0,Dysphonia,16784529,6
5,22.0,Fatigue,16784529,6
6,22.0,Blood pressure increased,16784529,1
0,22.0,Chills,16784575,1
1,22.0,Body temperature increased,16784575,1
2,22.0,Hypertension,16784575,1
3,22.0,Sinus tachycardia,16784575,1
4,22.0,Oxygen saturation decreased,16784575,1
0,22.1,Dyspepsia,16784590,6
1,22.1,Pain in extremity,16784590,6
2,22.1,Back pain,16784590,6
3,22.1,Fatigue,16784590,6
4,22.1,Urinary incontinence,16784590,3
5,22.1,Breast pain,16784590,3
6,22.1,Stress urinary incontinence,16784590,3
7,22.1,Restless legs syndrome,16784590,3
8,22.1,Headache,16784590,6
9,22.1,Asthenia,16784590,3
10,22.1,Loss of consciousness,16784590,6
11,22.1,Temperature intolerance,16784590,6
12,22.1,Sleep talking,16784590,6
13,22.1,Burning sensation,16784590,6
14,22.1,Arthralgia,16784590,6
15,22.1,Dizziness,16784590,3
16,22.1,Decreased appetite,16784590,6
17,22.1,Arthritis,16784590,6
18,22.1,Anhedonia,16784590,3
19,22.1,Dyspnoea,16784590,3
20,22.1,Muscular weakness,16784590,6
21,22.1,Myalgia,16784590,3
22,22.1,Hot flush,16784590,6
23,22.1,Breast mass,16784590,3
24,22.1,Attention deficit/hyperactivity disorder,16784590,3
25,22.1,Malaise,16784590,6
26,22.1,Depression,16784590,6
27,22.1,Initial insomnia,16784590,3
28,22.1,Hyperhidrosis,16784590,3
29,22.1,Flushing,16784590,6
30,22.1,Diarrhoea,16784590,6
31,22.1,Underdose,16784590,6
32,22.1,Pyrexia,16784590,6
33,22.1,Somnolence,16784590,6
34,22.1,Nausea,16784590,3
0,22.0,Infection,16784616,6
1,22.0,Mucosal inflammation,16784616,6
2,22.0,Impaired healing,16784616,6
3,22.0,Pleural disorder,16784616,6
4,22.0,Intestinal obstruction,16784616,6
5,22.0,Neurotoxicity,16784616,6
6,22.0,Sepsis,16784616,6
7,22.0,Haemorrhage,16784616,6
8,22.0,Vomiting,16784616,6
9,22.0,Neuropathy peripheral,16784616,6
10,22.0,Pneumonia,16784616,6
11,22.0,Febrile neutropenia,16784616,6
12,22.0,Neutropenia,16784616,6
13,22.0,Hypersensitivity,16784616,6
14,22.0,Anaemia,16784616,6
15,22.0,Abdominal infection,16784616,6
16,22.0,Asthenia,16784616,6
17,22.0,Thrombocytopenia,16784616,6
18,22.0,Diarrhoea,16784616,6
19,22.0,Nausea,16784616,6
0,22.0,Pancytopenia,16784620,5
1,22.0,Anaemia,16784620,5
2,22.0,Sepsis,16784620,5
3,22.0,Hypotension,16784620,5
4,22.0,Fatigue,16784620,5
5,22.0,Laboratory test abnormal,16784620,5
6,22.0,Myelodysplastic syndrome,16784620,5
7,22.0,Unresponsive to stimuli,16784620,5
8,22.0,Non-Hodgkin^s lymphoma,16784620,5
0,22.0,Disease progression,16784637,3
1,22.0,Drug ineffective,16784637,6
0,22.0,Migraine with aura,16784656,3
0,22.0,Renal failure,16784674,5
0,22.0,Inappropriate schedule of product administration,16784757,6
1,22.0,Febrile neutropenia,16784757,1
2,22.0,Wrong technique in product usage process,16784757,6
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,16784808,6
1,22.0,Diarrhoea,16784808,6
2,22.0,Bone marrow failure,16784808,6
0,22.0,Diplopia,16784813,6
1,22.0,Hypokalaemia,16784813,6
2,22.0,Dyspnoea,16784813,6
3,22.0,Tremor,16784813,6
4,22.0,Dysarthria,16784813,6
0,22.1,Body temperature increased,16784823,1
1,22.1,Vitamin D deficiency,16784823,3
2,22.1,Neoplasm progression,16784823,6
3,22.1,Breast cancer recurrent,16784823,6
4,22.1,Asthma,16784823,3
5,22.1,Nail discolouration,16784823,3
0,22.0,Colorectal cancer metastatic,16784887,5
0,22.0,Radiation pneumonitis,16784906,6
1,22.0,Malignant neoplasm progression,16784906,6
0,22.1,Application site exfoliation,16784923,1
1,22.1,Incorrect product administration duration,16784923,6
2,22.1,Product use in unapproved indication,16784923,6
3,22.1,Application site burn,16784923,1
4,22.1,Product storage error,16784923,6
5,22.1,Application site pain,16784923,1
0,22.0,Myelodysplastic syndrome,16784964,2
0,22.0,Bone marrow failure,16785023,2
0,22.0,Surgery,16785024,6
0,22.0,Hepatopulmonary syndrome,16785153,6
0,22.0,Liver function test increased,16785192,3
1,22.0,Platelet count decreased,16785192,3
2,22.0,Intentional product use issue,16785192,6
3,22.0,Off label use,16785192,6
0,22.0,Lung disorder,16785260,2
0,22.0,Decreased appetite,16785265,2
1,22.0,Cognitive disorder,16785265,1
2,22.0,Diarrhoea,16785265,2
3,22.0,Loss of personal independence in daily activities,16785265,2
4,22.0,Vitamin B1 decreased,16785265,1
0,22.0,Diarrhoea,16785266,2
1,22.0,Decreased appetite,16785266,3
2,22.0,Dyspnoea,16785266,3
3,22.0,Pleural effusion,16785266,2
4,22.0,Abdominal discomfort,16785266,3
5,22.0,Fatigue,16785266,3
0,22.0,Congestive cardiomyopathy,16785335,3
0,22.0,Pneumonitis,16785359,1
1,22.0,Splenomegaly,16785359,1
2,22.0,Urinary tract infection,16785359,1
0,22.1,Acute kidney injury,16785362,6
1,22.1,Diarrhoea,16785362,2
0,22.0,Anaphylactic shock,16785403,6
0,22.0,Pyrexia,16785428,1
1,22.0,Rash erythematous,16785428,1
2,22.0,Rash,16785428,1
3,22.0,Intertrigo,16785428,1
4,22.0,Rash pruritic,16785428,1
5,22.0,Toxic erythema of chemotherapy,16785428,1
6,22.0,Skin exfoliation,16785428,1
7,22.0,Photosensitivity reaction,16785428,1
8,22.0,Nausea,16785428,1
0,22.1,Cystitis,16785445,1
1,22.1,Kidney infection,16785445,1
2,22.1,Gastrointestinal infection,16785445,1
0,22.0,Campylobacter gastroenteritis,16785471,2
0,22.0,Hypokalaemia,16785496,3
0,22.0,Malignant neoplasm progression,16785513,5
1,22.0,Intentional product use issue,16785513,6
2,22.0,Off label use,16785513,6
0,22.1,Pneumonia cryptococcal,16785543,6
1,22.1,Immune system disorder,16785543,6
0,22.1,Death,16785547,5
1,22.1,Dysphonia,16785547,6
2,22.1,Alopecia,16785547,6
3,22.1,Throat cancer,16785547,6
4,22.1,Second primary malignancy,16785547,6
0,22.0,Diarrhoea haemorrhagic,16785560,1
1,22.0,Colitis,16785560,2
2,22.0,Stomatitis,16785560,2
3,22.0,Bone marrow failure,16785560,2
0,22.0,Pruritus,16785597,6
0,22.1,Alopecia,16785617,3
1,22.1,Hair disorder,16785617,3
2,22.1,Hair colour changes,16785617,3
3,22.1,Hair texture abnormal,16785617,3
4,22.1,Madarosis,16785617,3
0,22.1,Confusional state,16785621,1
0,22.0,Female genital tract fistula,16785652,3
0,22.0,Aneurysm,16785687,2
1,22.0,Dizziness postural,16785687,6
2,22.0,Influenza,16785687,2
0,22.0,Death,16785697,5
1,22.0,Prostate cancer,16785697,6
0,22.0,Skin infection,16785698,1
1,22.0,Photosensitivity reaction,16785698,1
2,22.0,Decreased appetite,16785698,6
3,22.0,Drug eruption,16785698,1
0,22.0,Death,16785701,5
1,22.0,Drug resistance,16785701,6
0,22.0,Stevens-Johnson syndrome,16785703,6
1,22.0,Rash,16785703,6
0,22.0,Pain,16785704,6
0,22.0,Pruritus generalised,16785707,6
1,22.0,Erythema,16785707,6
0,22.0,Fatigue,16785732,6
1,22.0,Stomatitis,16785732,1
2,22.0,White blood cell count decreased,16785732,6
0,22.1,White blood cell count decreased,16785756,6
1,22.1,Stomatitis,16785756,6
2,22.1,Headache,16785756,6
3,22.1,Pain,16785756,6
0,22.1,Neutropenia,16785848,2
0,22.1,Fatigue,16785916,1
1,22.1,Neutropenia,16785916,6
2,22.1,Back pain,16785916,1
3,22.1,Anaemia,16785916,6
4,22.1,Decreased appetite,16785916,1
5,22.1,Weight decreased,16785916,1
6,22.1,Nausea,16785916,1
7,22.1,Diarrhoea,16785916,1
0,22.0,Taste disorder,16785917,6
1,22.0,Nausea,16785917,6
2,22.0,Bone marrow failure,16785917,6
3,22.0,Fatigue,16785917,3
4,22.0,Alopecia,16785917,6
0,22.0,Drug intolerance,16785941,6
1,22.0,Gastritis erosive,16785941,6
0,22.0,Night sweats,16785944,3
1,22.0,Viral infection,16785944,1
2,22.0,Fatigue,16785944,2
0,22.1,Insomnia,16785973,6
1,22.1,Neutrophil count decreased,16785973,1
0,22.0,Death,16786020,5
0,22.0,Death,16786029,5
0,22.0,Death,16786059,5
0,22.1,Dyspnoea,16786090,6
1,22.1,Diarrhoea,16786090,6
2,22.1,Rash,16786090,6
3,22.1,Intentional product use issue,16786090,6
0,22.0,Death,16786122,5
0,22.1,Second primary malignancy,16786138,3
1,22.1,Bladder cancer,16786138,3
0,22.1,Malignant neoplasm progression,16786160,5
1,22.1,Immune-mediated enterocolitis,16786160,2
2,22.1,Small intestinal perforation,16786160,2
3,22.1,Enteritis,16786160,6
0,22.0,Product use issue,16786164,6
1,22.0,Haematotoxicity,16786164,1
2,22.0,Neuropathy peripheral,16786164,3
3,22.0,Malaise,16786164,2
0,22.0,Nausea,16786216,1
1,22.0,Abdominal pain,16786216,3
2,22.0,Vomiting,16786216,1
0,22.0,Metastases to central nervous system,16786226,5
1,22.0,Brain neoplasm,16786226,5
2,22.0,Asthenia,16786226,6
3,22.0,Limb discomfort,16786226,6
4,22.0,Dysphemia,16786226,6
5,22.0,Nerve compression,16786226,5
6,22.0,Decreased appetite,16786226,6
7,22.0,Malignant neoplasm progression,16786226,5
0,22.1,Pulmonary fibrosis,16786232,3
0,22.0,Respiratory rate increased,16786266,6
1,22.0,Gastrointestinal disorder,16786266,6
2,22.0,Urinary retention,16786266,6
3,22.0,Prostate cancer,16786266,6
0,22.0,Chest pain,16786278,6
1,22.0,Neutropenia,16786278,6
2,22.0,White blood cell count decreased,16786278,6
3,22.0,Decreased appetite,16786278,6
0,22.1,Pneumonitis,16786353,1
0,22.0,Pancytopenia,16786356,1
1,22.0,Rhabdomyolysis,16786356,1
2,22.0,Urosepsis,16786356,1
0,22.0,Haptoglobin decreased,16786440,3
1,22.0,Haemolysis,16786440,3
0,22.0,Death,16786446,5
0,22.1,Asthenia,16786451,1
1,22.1,Rash,16786451,1
2,22.1,Stevens-Johnson syndrome,16786451,6
3,22.1,Blood creatinine increased,16786451,2
4,22.1,Hyperglycaemia,16786451,6
5,22.1,Acute kidney injury,16786451,1
0,22.1,Prostate cancer metastatic,16786473,5
0,22.0,Death,16786479,5
0,22.1,Death,16786482,5
1,22.1,Intentional product use issue,16786482,6
0,22.0,Pyrexia,16786498,1
1,22.0,Pruritus,16786498,1
2,22.0,Chest discomfort,16786498,1
3,22.0,Dizziness,16786498,1
4,22.0,Flushing,16786498,1
5,22.0,Chills,16786498,1
6,22.0,Temperature intolerance,16786498,1
0,22.0,Lower respiratory tract infection,16786500,6
1,22.0,Pyrexia,16786500,6
2,22.0,Dyspnoea,16786500,3
3,22.0,Pneumonia,16786500,1
0,22.1,Acute promyelocytic leukaemia,16786503,2
1,22.1,Leukopenia,16786503,6
0,22.0,Nephrolithiasis,16786556,6
1,22.0,Ureterolithiasis,16786556,6
0,22.1,Alanine aminotransferase increased,16786563,1
1,22.1,Aspartate aminotransferase increased,16786563,1
0,22.1,Decreased appetite,16786574,1
0,22.0,Bone marrow failure,16786577,1
0,22.0,Jaw disorder,16786632,6
0,22.1,Hospitalisation,16786703,6
0,22.1,Neutropenia,16786738,1
0,22.1,Interstitial lung disease,16786764,5
1,22.1,Acute respiratory failure,16786764,5
2,22.1,Febrile neutropenia,16786764,2
0,22.0,Death,16786765,5
1,22.0,Pancreatitis,16786765,6
0,22.0,Death,16786812,5
1,22.0,Drug resistance,16786812,6
2,22.0,Malignant neoplasm progression,16786812,6
0,22.0,Metastases to central nervous system,16786815,6
1,22.0,Death,16786815,5
2,22.0,Disease progression,16786815,6
0,22.0,Death,16786817,5
1,22.0,Metastasis,16786817,6
2,22.0,Malignant neoplasm progression,16786817,6
0,22.0,Pancreatitis acute,16786832,1
0,22.0,Ventricular dysfunction,16786840,6
1,22.0,Hypothyroidism,16786840,6
0,22.0,Product dose omission,16786897,6
1,22.0,Product prescribing error,16786897,6
2,22.0,Off label use,16786897,6
0,22.0,Prostatic specific antigen decreased,16786910,3
1,22.0,Insomnia,16786910,6
2,22.0,Off label use,16786910,6
3,22.0,Weight decreased,16786910,3
4,22.0,Sinus disorder,16786910,3
5,22.0,Muscle atrophy,16786910,3
6,22.0,Blood testosterone abnormal,16786910,3
7,22.0,Respiratory disorder,16786910,6
8,22.0,Incorrect dose administered,16786910,6
0,22.0,Metastases to meninges,16786919,5
1,22.0,Malignant neoplasm progression,16786919,6
2,22.0,Dizziness,16786919,3
3,22.0,Vomiting,16786919,6
0,22.0,Metastatic neoplasm,16786921,5
1,22.0,Metastasis,16786921,5
2,22.0,Malignant neoplasm progression,16786921,5
0,22.0,Recall phenomenon,16786922,1
1,22.0,Intertrigo,16786922,1
0,22.0,Cardiopulmonary failure,16786929,5
0,22.1,Stomatitis,16786944,3
1,22.1,Acne,16786944,3
2,22.1,Mouth ulceration,16786944,3
3,22.1,Skin fissures,16786944,3
4,22.1,Skin disorder,16786944,3
5,22.1,Skin disorder,16786944,6
6,22.1,Rash,16786944,3
7,22.1,Gastroenteritis viral,16786944,1
8,22.1,Non-small cell lung cancer,16786944,3
9,22.1,Pruritus,16786944,3
10,22.1,Decreased appetite,16786944,3
11,22.1,Pruritus,16786944,6
12,22.1,Paronychia,16786944,6
13,22.1,Nail disorder,16786944,3
14,22.1,Diarrhoea,16786944,1
0,22.1,Alopecia,16786962,2
1,22.1,Pain,16786962,6
2,22.1,Anxiety,16786962,6
3,22.1,Emotional distress,16786962,6
4,22.1,Impaired quality of life,16786962,6
5,22.1,Psychological trauma,16786962,6
0,22.1,Emotional distress,16786978,6
1,22.1,Psychological trauma,16786978,6
2,22.1,Alopecia,16786978,2
3,22.1,Impaired quality of life,16786978,6
4,22.1,Pain,16786978,6
5,22.1,Anxiety,16786978,6
0,22.1,Emotional distress,16786979,6
1,22.1,Pain,16786979,6
2,22.1,Psychological trauma,16786979,6
3,22.1,Alopecia,16786979,2
4,22.1,Impaired quality of life,16786979,6
5,22.1,Anxiety,16786979,6
0,22.1,Anxiety,16786981,6
1,22.1,Impaired quality of life,16786981,6
2,22.1,Emotional distress,16786981,6
3,22.1,Pain,16786981,6
4,22.1,Psychological trauma,16786981,6
5,22.1,Alopecia,16786981,2
0,22.1,Emotional distress,16786987,6
1,22.1,Impaired quality of life,16786987,6
2,22.1,Alopecia,16786987,2
3,22.1,Anxiety,16786987,6
4,22.1,Pain,16786987,6
5,22.1,Psychological trauma,16786987,6
0,22.1,Anxiety,16786988,6
1,22.1,Psychological trauma,16786988,6
2,22.1,Emotional distress,16786988,6
3,22.1,Alopecia,16786988,2
4,22.1,Pain,16786988,6
5,22.1,Impaired quality of life,16786988,6
0,22.1,Anxiety,16786992,6
1,22.1,Alopecia,16786992,3
2,22.1,Impaired quality of life,16786992,6
3,22.1,Emotional distress,16786992,6
4,22.1,Pain,16786992,6
5,22.1,Psychological trauma,16786992,6
0,22.0,Death,16787017,5
1,22.0,Drug resistance,16787017,6
2,22.0,Malignant neoplasm progression,16787017,6
0,22.1,Alopecia,16787053,2
0,22.1,Pain,16787056,6
1,22.1,Psychological trauma,16787056,6
2,22.1,Anxiety,16787056,6
3,22.1,Emotional distress,16787056,6
4,22.1,Alopecia,16787056,3
5,22.1,Impaired quality of life,16787056,6
0,22.1,Alopecia,16787065,2
0,22.1,Alopecia,16787068,2
1,22.1,Psychological trauma,16787068,6
0,22.1,Alopecia,16787071,2
1,22.1,Pain,16787071,6
2,22.1,Anxiety,16787071,6
3,22.1,Emotional distress,16787071,6
4,22.1,Impaired quality of life,16787071,6
5,22.1,Psychological trauma,16787071,6
0,22.1,Psychological trauma,16787082,6
1,22.1,Emotional distress,16787082,6
2,22.1,Pain,16787082,6
3,22.1,Anxiety,16787082,6
4,22.1,Alopecia,16787082,2
5,22.1,Impaired quality of life,16787082,6
0,22.1,Impaired quality of life,16787083,6
1,22.1,Anxiety,16787083,6
2,22.1,Psychological trauma,16787083,6
3,22.1,Emotional distress,16787083,6
4,22.1,Alopecia,16787083,2
5,22.1,Pain,16787083,6
0,22.1,Emotional distress,16787092,6
1,22.1,Alopecia,16787092,2
2,22.1,Anxiety,16787092,6
3,22.1,Pain,16787092,6
4,22.1,Impaired quality of life,16787092,6
5,22.1,Psychological trauma,16787092,6
6,22.1,Exposure during pregnancy,16787092,6
0,22.0,Bradycardia,16787103,2
0,22.1,Alopecia,16787143,2
1,22.1,Emotional distress,16787143,6
2,22.1,Impaired quality of life,16787143,6
3,22.1,Psychological trauma,16787143,6
4,22.1,Anxiety,16787143,6
5,22.1,Pain,16787143,6
0,22.1,Anxiety,16787153,6
1,22.1,Emotional distress,16787153,6
2,22.1,Impaired quality of life,16787153,6
3,22.1,Psychological trauma,16787153,6
4,22.1,Alopecia,16787153,1
5,22.1,Pain,16787153,6
0,22.1,Alopecia,16787219,3
1,22.1,Emotional distress,16787219,6
2,22.1,Anxiety,16787219,6
3,22.1,Pain,16787219,6
4,22.1,Impaired quality of life,16787219,6
0,22.1,Alopecia,16787222,2
0,22.1,Alopecia,16787228,3
1,22.1,Psychological trauma,16787228,6
0,22.1,Alopecia,16787233,2
1,22.1,Anxiety,16787233,6
2,22.1,Impaired quality of life,16787233,6
3,22.1,Pain,16787233,6
4,22.1,Emotional distress,16787233,6
0,22.0,Off label use,16787247,6
1,22.0,Polyarthritis,16787247,4
0,22.0,Drug resistance,16787253,6
0,22.1,Hair texture abnormal,16787261,3
1,22.1,Alopecia,16787261,3
2,22.1,Madarosis,16787261,3
3,22.1,Hair disorder,16787261,3
4,22.1,Hair colour changes,16787261,3
0,22.0,Hypoacusis,16787263,6
0,22.1,Pouchitis,16787281,6
1,22.1,Impaired healing,16787281,6
2,22.1,Suture rupture,16787281,2
0,22.0,Respiratory failure,16787284,4
1,22.0,Dyspnoea,16787284,4
0,22.0,Deafness unilateral,16787292,3
1,22.0,Dizziness,16787292,3
0,22.0,Chromaturia,16787340,6
1,22.0,Fatigue,16787340,6
2,22.0,Liver injury,16787340,6
3,22.0,Faeces pale,16787340,6
4,22.0,Jaundice cholestatic,16787340,3
0,22.1,Myocarditis,16787355,5
1,22.1,Pneumonia,16787355,1
2,22.1,Pneumonia,16787355,1
3,22.1,Sepsis,16787355,5
0,22.0,Paraplegia,16787364,6
1,22.0,Inappropriate schedule of product administration,16787364,6
0,22.0,Abnormal loss of weight,16787425,2
1,22.0,Hypertension,16787425,2
2,22.0,Decreased appetite,16787425,2
0,22.0,Product dose omission,16787470,6
1,22.0,Visual acuity reduced,16787470,3
2,22.0,Product label issue,16787470,6
3,22.0,Confusional state,16787470,3
0,22.0,Anaphylactic shock,16787503,6
0,22.0,Haemoptysis,16787541,1
1,22.0,Haemoglobin decreased,16787541,
0,22.0,Anaphylactic shock,16787551,6
0,22.1,Syncope,16787556,2
1,22.1,Lacrimation increased,16787556,3
2,22.1,Circulatory collapse,16787556,1
3,22.1,Abdominal pain lower,16787556,2
4,22.1,Constipation,16787556,2
5,22.1,Weight decreased,16787556,6
0,22.0,Product use in unapproved indication,16787568,6
0,22.0,Endometrial thickening,16787573,6
1,22.0,Vaginal haemorrhage,16787573,6
2,22.0,Postmenopausal haemorrhage,16787573,6
0,22.1,White blood cell count decreased,16787587,
1,22.1,Therapy change,16787587,
0,22.1,Death,16787609,
0,22.1,Disease progression,16787615,
0,22.1,Diarrhoea,16787616,3
1,22.1,Nasopharyngitis,16787616,6
2,22.1,Fatigue,16787616,3
3,22.1,Hypercalcaemia,16787616,6
4,22.1,Rhinorrhoea,16787616,6
5,22.1,Bone marrow failure,16787616,6
6,22.1,Weight decreased,16787616,6
7,22.1,Nausea,16787616,1
8,22.1,Decreased appetite,16787616,6
0,22.1,Haemorrhage,16787630,
0,22.1,Renal disorder,16787670,6
1,22.1,Syringe issue,16787670,
2,22.1,Complication associated with device,16787670,6
3,22.1,Product preparation error,16787670,
0,22.1,Feeling hot,16787679,6
1,22.1,Injection site erythema,16787679,3
2,22.1,Pain in extremity,16787679,3
3,22.1,Sinus congestion,16787679,6
4,22.1,Dyspnoea exertional,16787679,3
5,22.1,Inflammatory pain,16787679,6
6,22.1,Lymphocele,16787679,3
7,22.1,Infection,16787679,3
8,22.1,Fatigue,16787679,3
9,22.1,Pyrexia,16787679,3
10,22.1,Blood pressure decreased,16787679,6
11,22.1,Dysgeusia,16787679,6
12,22.1,Joint swelling,16787679,3
13,22.1,Injection site swelling,16787679,3
14,22.1,Hot flush,16787679,1
15,22.1,Dizziness,16787679,3
16,22.1,Asthenia,16787679,3
17,22.1,Local reaction,16787679,6
18,22.1,Vomiting,16787679,3
19,22.1,Bone pain,16787679,6
0,22.1,Alcoholic pancreatitis,16787683,1
0,22.1,Myocardial infarction,16787698,1
1,22.1,Respiratory distress,16787698,5
2,22.1,Cardiac failure,16787698,3
0,22.1,Neoplasm progression,16787701,5
0,22.0,Off label use,16787707,6
0,22.0,Drug ineffective,16787708,3
0,22.0,Death,16787712,5
0,22.0,Death,16787713,5
0,22.0,Pneumonia,16787734,1
0,22.1,Drug ineffective,16787826,6
1,22.1,Vertigo,16787826,6
2,22.1,Chest discomfort,16787826,6
3,22.1,Fungal infection,16787826,6
4,22.1,Pyrexia,16787826,6
5,22.1,Bladder disorder,16787826,6
6,22.1,Stomatitis,16787826,6
7,22.1,Headache,16787826,6
8,22.1,Dizziness,16787826,6
9,22.1,Rash,16787826,6
10,22.1,Product use in unapproved indication,16787826,6
0,22.1,Product use in unapproved indication,16787829,6
1,22.1,Dry skin,16787829,6
2,22.1,Skin exfoliation,16787829,6
3,22.1,Diarrhoea,16787829,6
4,22.1,Hair growth abnormal,16787829,6
5,22.1,Acne,16787829,6
0,22.1,Pneumonia bacterial,16787868,6
1,22.1,Hypophagia,16787868,6
0,22.0,Hypoxia,16787898,2
0,22.1,Abdominal pain,16787901,3
1,22.1,Diarrhoea,16787901,6
2,22.1,Nausea,16787901,6
3,22.1,Feeling abnormal,16787901,6
4,22.1,Intestinal obstruction,16787901,6
5,22.1,Insomnia,16787901,3
6,22.1,Back pain,16787901,6
7,22.1,Dysphonia,16787901,6
8,22.1,Constipation,16787901,3
9,22.1,Fatigue,16787901,6
0,22.0,Pyrexia,16787913,6
1,22.0,Neutropenia,16787913,6
2,22.0,Thrombocytopenia,16787913,6
3,22.0,Joint swelling,16787913,2
4,22.0,Rash,16787913,2
5,22.0,Ear swelling,16787913,6
6,22.0,Immune-mediated adverse reaction,16787913,6
0,22.1,Decreased appetite,16787949,1
1,22.1,Adrenal insufficiency,16787949,1
2,22.1,Malignant neoplasm progression,16787949,5
3,22.1,Drug ineffective,16787949,5
4,22.1,Nausea,16787949,1
5,22.1,Asthenia,16787949,1
0,22.0,Jaundice,16788035,4
1,22.0,Alanine aminotransferase increased,16788035,3
2,22.0,Blood alkaline phosphatase increased,16788035,3
3,22.0,Gamma-glutamyltransferase increased,16788035,3
0,22.0,Drug resistance,16788040,6
1,22.0,Malignant neoplasm progression,16788040,6
0,22.0,Hepatic cirrhosis,16788048,6
1,22.0,Portal hypertension,16788048,6
0,22.0,Ischaemic stroke,16788065,6
1,22.0,Blindness,16788065,6
0,22.1,Blood creatinine decreased,16788083,6
1,22.1,Photosensitivity reaction,16788083,1
2,22.1,Nasopharyngitis,16788083,6
3,22.1,Weight decreased,16788083,1
4,22.1,Fatigue,16788083,3
5,22.1,Eye infection,16788083,1
6,22.1,Hydronephrosis,16788083,3
7,22.1,Nephrolithiasis,16788083,1
8,22.1,Dehydration,16788083,6
9,22.1,Nausea,16788083,1
10,22.1,Positron emission tomogram abnormal,16788083,1
11,22.1,Rash,16788083,1
12,22.1,Carbohydrate antigen 125 increased,16788083,3
0,22.0,Bone marrow failure,16788091,2
0,22.0,General physical health deterioration,16788132,6
0,22.1,Neck pain,16788165,3
1,22.1,Dizziness,16788165,1
2,22.1,Paraesthesia,16788165,1
3,22.1,Thrombocytopenia,16788165,1
4,22.1,Neutropenia,16788165,1
5,22.1,Hypogeusia,16788165,3
6,22.1,Weight increased,16788165,6
7,22.1,Pleural effusion,16788165,1
8,22.1,Vomiting,16788165,1
9,22.1,Weight decreased,16788165,6
10,22.1,Palmar-plantar erythrodysaesthesia syndrome,16788165,3
11,22.1,Metastases to pleura,16788165,6
12,22.1,Skin disorder,16788165,3
13,22.1,Metastases to lymph nodes,16788165,6
14,22.1,Fatigue,16788165,3
0,22.1,Thrombocytopenia,16788166,1
1,22.1,Leukopenia,16788166,1
2,22.1,Anaemia,16788166,3
3,22.1,Septic shock,16788166,1
0,22.1,Fall,16788196,6
1,22.1,Hypophagia,16788196,3
2,22.1,Incontinence,16788196,3
3,22.1,Muscular weakness,16788196,3
4,22.1,Aggression,16788196,3
5,22.1,Sleep disorder,16788196,3
6,22.1,Gait disturbance,16788196,3
0,22.1,Leukopenia,16788267,1
1,22.1,Seroma,16788267,1
0,22.0,Metastases to central nervous system,16788299,6
1,22.0,Pneumonitis,16788299,6
2,22.0,Metastases to meninges,16788299,5
0,22.0,Skin lesion,16788333,3
1,22.0,Pruritus,16788333,3
2,22.0,Product dose omission,16788333,6
3,22.0,Urticaria,16788333,3
0,22.0,Neurotoxicity,16788338,6
0,22.0,Malignant neoplasm progression,16788367,6
1,22.0,Breast cancer,16788367,6
2,22.0,Metastases to liver,16788367,6
3,22.0,Metastases to bone,16788367,6
0,22.0,Non-small cell lung cancer,16788368,5
0,22.0,Bone marrow failure,16788387,1
0,22.0,Epistaxis,16788404,6
1,22.0,Pancytopenia,16788404,6
2,22.0,Carbohydrate antigen 125 increased,16788404,6
3,22.0,Death,16788404,5
0,22.1,Torsade de pointes,16788420,1
0,22.0,Metastases to peritoneum,16788432,6
1,22.0,Sepsis,16788432,6
2,22.0,Cholecystitis acute,16788432,6
3,22.0,Ascites,16788432,6
4,22.0,Subileus,16788432,6
0,22.0,Bone marrow failure,16788457,1
0,22.1,Cardiac failure,16788555,2
0,22.1,Appendicitis,16788579,1
0,22.0,Angioedema,16788624,2
0,22.0,White blood cell count decreased,16788662,2
0,22.0,Neutrophil count decreased,16788690,2
1,22.0,Gingival bleeding,16788690,1
2,22.0,Perinephric abscess,16788690,6
3,22.0,Dysphonia,16788690,2
4,22.0,Hypertension,16788690,1
0,22.0,Pleurisy,16788709,3
0,22.0,Off label use,16788730,6
1,22.0,Febrile neutropenia,16788730,6
2,22.0,Coronary artery dissection,16788730,6
0,22.0,Infusion site reaction,16788858,2
1,22.0,Skin hyperpigmentation,16788858,2
0,22.1,Colitis,16788866,1
1,22.1,Pancytopenia,16788866,6
0,22.0,Orthostatic hypotension,16788886,1
0,22.0,Polyneuropathy,16788892,2
0,22.0,Breast cancer metastatic,16788908,6
1,22.0,Malignant neoplasm progression,16788908,6
0,22.0,Metastases to lung,16788912,6
1,22.0,Disease progression,16788912,6
0,22.0,Acute kidney injury,16789004,1
1,22.0,Febrile neutropenia,16789004,1
2,22.0,Intentional product use issue,16789004,6
0,22.0,Upper gastrointestinal haemorrhage,16789005,1
1,22.0,Intentional product use issue,16789005,6
2,22.0,Acute kidney injury,16789005,1
0,22.1,No adverse event,16789009,6
0,22.0,Intentional product use issue,16789013,6
1,22.0,Septic shock,16789013,1
2,22.0,Acute kidney injury,16789013,1
0,22.0,Sepsis,16789039,1
1,22.0,Diarrhoea,16789039,1
0,22.0,Colitis ulcerative,16789049,6
0,22.0,Pneumonia,16789056,6
1,22.0,Respiratory failure,16789056,6
2,22.0,Interstitial lung disease,16789056,1
0,22.0,Movement disorder,16789097,6
0,22.1,Lung disorder,16789114,2
0,22.0,Metastases to bone,16789120,6
0,22.0,Bone marrow failure,16789144,6
0,22.0,Back pain,16789145,1
0,22.0,Rhabdomyolysis,16789176,1
1,22.0,Pancytopenia,16789176,1
2,22.0,Urosepsis,16789176,1
0,22.0,Rash,16789178,6
1,22.0,Alopecia,16789178,6
2,22.0,Fatigue,16789178,6
0,22.0,Tooth fracture,16789233,3
0,22.0,Transitional cell carcinoma,16789284,3
0,22.1,Gastrointestinal disorder,16789324,3
1,22.1,Malnutrition,16789324,3
2,22.1,Drug ineffective,16789324,6
0,22.0,Gynaecomastia,16789346,3
0,22.0,Intertrigo,16789420,1
1,22.0,Recall phenomenon,16789420,1
0,22.0,Asthenia,16789502,6
1,22.0,Skin lesion,16789502,6
0,22.0,Anaemia,16789508,2
0,22.0,Small cell lung cancer,16789525,6
1,22.0,Intestinal obstruction,16789525,6
0,22.0,Urinary tract infection,16789529,6
1,22.0,Aggression,16789529,6
0,22.0,Drug resistance,16789612,6
1,22.0,Malignant neoplasm progression,16789612,6
0,22.1,Nausea,16789626,2
1,22.1,Vomiting,16789626,2
2,22.1,Aphthous ulcer,16789626,2
0,22.1,Diarrhoea,16789627,2
1,22.1,Amnesia,16789627,2
2,22.1,Paraesthesia,16789627,2
3,22.1,Fatigue,16789627,2
0,22.0,Hyponatraemia,16789629,2
0,22.1,Hypoacusis,16789636,6
1,22.1,Bladder disorder,16789636,6
2,22.1,Feeding disorder,16789636,1
3,22.1,Somnolence,16789636,6
0,22.0,Anaphylactic shock,16789694,6
0,22.1,Scrotal oedema,16789731,2
1,22.1,Rash,16789731,2
2,22.1,Oedema peripheral,16789731,2
0,22.0,Pain,16789755,6
1,22.0,Alopecia,16789755,3
2,22.0,Emotional distress,16789755,6
3,22.0,Impaired quality of life,16789755,6
4,22.0,Anxiety,16789755,6
5,22.0,Psychological trauma,16789755,6
0,22.0,Metastases to bone,16789760,6
0,22.0,Pneumonia,16789837,6
1,22.0,Nasopharyngitis,16789837,6
2,22.0,Folliculitis,16789837,6
3,22.0,Herpes zoster,16789837,6
4,22.0,Skin infection,16789837,6
5,22.0,Oral candidiasis,16789837,6
6,22.0,Upper respiratory tract infection,16789837,6
7,22.0,Urinary tract infection,16789837,6
8,22.0,Infection,16789837,6
9,22.0,Fungal infection,16789837,6
10,22.0,Herpes simplex,16789837,6
11,22.0,Lower respiratory tract infection,16789837,6
12,22.0,Toxic skin eruption,16789837,6
0,22.1,Ileus,16789851,3
1,22.1,Hyperphosphataemia,16789851,6
2,22.1,Mucosal inflammation,16789851,3
3,22.1,Disease progression,16789851,5
4,22.1,Vomiting,16789851,6
0,22.0,Death,16789873,5
0,22.0,Death,16789875,5
0,22.0,Death,16789876,5
0,22.0,Death,16789877,5
0,22.0,Death,16789878,5
0,22.0,Immune-mediated enterocolitis,16789907,5
1,22.0,Acute coronary syndrome,16789907,6
0,22.0,Death,16789916,5
0,22.0,Death,16789918,5
0,22.0,Death,16789919,5
0,22.0,Death,16789920,5
0,22.0,Death,16789921,5
0,22.0,Anaemia,16789959,3
1,22.0,Haematoma,16789959,3
2,22.0,Pulmonary embolism,16789959,6
0,22.0,Hepatic cyst,16789960,6
1,22.0,Renal cyst,16789960,6
2,22.0,Cholecystitis,16789960,6
3,22.0,Intestinal perforation,16789960,6
4,22.0,Intestinal obstruction,16789960,6
0,22.0,Drug hypersensitivity,16789965,6
0,22.1,Skin haemorrhage,16789971,6
1,22.1,Dry skin,16789971,6
2,22.1,Constipation,16789971,6
3,22.1,Hand dermatitis,16789971,6
0,22.0,Alopecia,16789998,2
1,22.0,Psychological trauma,16789998,6
0,22.0,Cough,16790029,3
1,22.0,Rash,16790029,1
0,22.0,Pain in extremity,16790038,6
0,22.1,Alopecia,16790070,2
1,22.1,Psychological trauma,16790070,6
0,22.0,Psychological trauma,16790073,6
1,22.0,Alopecia,16790073,2
0,22.1,Lung disorder,16790079,5
1,22.1,Pneumocystis jirovecii pneumonia,16790079,5
0,22.1,Anxiety,16790082,6
1,22.1,Pain,16790082,6
2,22.1,Impaired quality of life,16790082,6
3,22.1,Emotional distress,16790082,6
4,22.1,Alopecia,16790082,2
5,22.1,Psychological trauma,16790082,6
0,22.1,Alopecia,16790090,3
1,22.1,Psychological trauma,16790090,6
0,22.1,Alopecia,16790091,2
1,22.1,Psychological trauma,16790091,6
0,22.0,Alopecia,16790092,2
0,22.1,Impaired quality of life,16790111,6
1,22.1,Emotional distress,16790111,6
2,22.1,Pain,16790111,6
3,22.1,Alopecia,16790111,2
4,22.1,Anxiety,16790111,6
5,22.1,Psychological trauma,16790111,6
0,22.0,Death,16790134,5
0,22.0,Death,16790135,5
0,22.0,Death,16790136,5
0,22.0,Death,16790137,5
0,22.0,Death,16790138,5
0,22.0,Immune-mediated enterocolitis,16790140,2
1,22.0,Drug ineffective,16790140,6
0,22.0,Malignant neoplasm progression,16790157,6
1,22.0,Cough,16790157,6
2,22.0,Decreased appetite,16790157,6
3,22.0,Drug resistance,16790157,6
0,22.0,Nasal disorder,16790180,6
1,22.0,Tonsillar disorder,16790180,6
2,22.0,Lower limb fracture,16790180,6
0,22.0,Peripheral sensory neuropathy,16790193,6
1,22.0,Headache,16790193,6
2,22.0,Alopecia,16790193,6
3,22.0,Epistaxis,16790193,6
4,22.0,Arthralgia,16790193,6
5,22.0,Nausea,16790193,6
6,22.0,Body temperature increased,16790193,6
7,22.0,Hepatotoxicity,16790193,6
8,22.0,Stomatitis,16790193,6
0,22.1,Upper respiratory tract infection,16790196,1
1,22.1,Carbohydrate antigen 125 increased,16790196,6
2,22.1,Neck pain,16790196,1
3,22.1,Chronic obstructive pulmonary disease,16790196,1
4,22.1,Pelvic pain,16790196,1
5,22.1,Tendonitis,16790196,1
6,22.1,Adverse event,16790196,2
7,22.1,Pneumonia,16790196,1
8,22.1,Dental caries,16790196,1
9,22.1,Hyponatraemia,16790196,1
10,22.1,Bronchospasm,16790196,1
11,22.1,Dyspnoea,16790196,1
0,22.1,Malignant neoplasm progression,16790205,5
1,22.1,Enteritis infectious,16790205,6
2,22.1,Diarrhoea,16790205,1
0,22.1,Therapeutic product effect decreased,16790221,
1,22.1,Dysphagia,16790221,
2,22.1,Oropharyngeal discomfort,16790221,
0,22.1,Pleural effusion,16790222,2
1,22.1,Aspartate aminotransferase increased,16790222,3
2,22.1,Dyspnoea,16790222,2
3,22.1,Blood creatinine increased,16790222,3
4,22.1,Dental caries,16790222,1
5,22.1,Blood urea increased,16790222,3
6,22.1,Alanine aminotransferase increased,16790222,2
7,22.1,Blood uric acid increased,16790222,3
8,22.1,Nausea,16790222,2
9,22.1,Weight decreased,16790222,6
10,22.1,Nausea,16790222,1
0,22.0,Dysphagia,16790233,3
1,22.0,Concomitant disease aggravated,16790233,3
2,22.0,Cachexia,16790233,3
0,22.0,Neutropenia,16790236,1
1,22.0,Dyspepsia,16790236,1
2,22.0,Nausea,16790236,1
3,22.0,Anaemia,16790236,1
4,22.0,Constipation,16790236,1
5,22.0,Glycosuria,16790236,1
6,22.0,Palmar-plantar erythrodysaesthesia syndrome,16790236,1
7,22.0,Stomatitis,16790236,1
8,22.0,Proteinuria,16790236,1
0,22.0,Renal impairment,16790296,6
1,22.0,Pyrexia,16790296,6
2,22.0,Stomatitis,16790296,6
3,22.0,Dehydration,16790296,6
4,22.0,Pneumocystis jirovecii pneumonia,16790296,2
0,22.1,Neutropenia,16790302,1
1,22.1,Pyrexia,16790302,1
0,22.1,Hypertensive crisis,16790303,1
1,22.1,Leukopenia,16790303,1
2,22.1,Neutropenia,16790303,1
3,22.1,Oedema peripheral,16790303,1
4,22.1,Neutropenia,16790303,1
0,22.1,Surgery,16790339,
0,22.1,Pyrexia,16790351,
1,22.1,Disease progression,16790351,
0,22.1,Hospitalisation,16790372,
0,22.0,Death,16790397,5
0,22.0,Death,16790400,5
0,22.0,Death,16790405,5
0,22.0,Death,16790406,5
0,22.0,Death,16790408,5
0,22.0,Intestinal perforation,16790450,3
0,22.1,Disease progression,16790522,
0,22.1,Cerebrovascular accident,16790524,
1,22.1,Arterial occlusive disease,16790524,
0,22.1,Death,16790542,
0,22.1,Gastrointestinal toxicity,16790545,
0,22.0,Thrombocytopenia,16790586,1
1,22.0,Product use in unapproved indication,16790586,6
2,22.0,Neutropenia,16790586,1
3,22.0,Off label use,16790586,6
4,22.0,Bone marrow failure,16790586,2
0,22.0,Diarrhoea,16790605,6
1,22.0,Hypokalaemia,16790605,1
2,22.0,Quadriplegia,16790605,1
0,22.0,Neoplasm progression,16790638,6
1,22.0,Pancytopenia,16790638,6
2,22.0,Febrile neutropenia,16790638,6
3,22.0,Infection,16790638,6
0,22.0,Pain,16790641,6
1,22.0,Neoplasm progression,16790641,6
2,22.0,Infection,16790641,6
3,22.0,Angina pectoris,16790641,6
4,22.0,Gait disturbance,16790641,6
5,22.0,Seizure,16790641,6
0,22.0,Hepatic lesion,16790650,6
0,22.0,Full blood count decreased,16790666,6
0,22.1,Neoplasm progression,16790671,6
0,22.1,Neoplasm progression,16790674,6
1,22.1,Off label use,16790674,6
2,22.1,Product use in unapproved indication,16790674,6
0,22.1,Fluid retention,16790679,
1,22.1,Abdominal distension,16790679,
0,22.1,Malaise,16790705,6
0,22.0,Alopecia,16790719,6
0,22.0,Alopecia,16790721,3
1,22.0,Hair colour changes,16790721,6
2,22.0,Madarosis,16790721,3
3,22.0,Depression,16790721,6
4,22.0,Hair texture abnormal,16790721,6
5,22.0,Hair disorder,16790721,6
0,22.1,Blood pressure increased,16790722,6
1,22.1,Spinal cord compression,16790722,2
2,22.1,Diarrhoea,16790722,1
3,22.1,Oropharyngeal pain,16790722,1
4,22.1,Fall,16790722,2
5,22.1,Blood urine present,16790722,6
0,22.0,Vomiting,16790738,6
0,22.0,Pleural effusion,16790742,2
0,22.1,Hot flush,16790755,6
1,22.1,Decreased appetite,16790755,6
2,22.1,Pruritus,16790755,6
3,22.1,Fatigue,16790755,6
4,22.1,Asthenia,16790755,6
5,22.1,Genital infection fungal,16790755,6
6,22.1,Abdominal discomfort,16790755,6
0,22.1,Oral mucosal blistering,16790782,3
1,22.1,Madarosis,16790782,3
2,22.1,Rash,16790782,6
3,22.1,Anaemia,16790782,3
4,22.1,Memory impairment,16790782,3
5,22.1,Alopecia,16790782,3
0,22.0,Quadriparesis,16790826,2
0,22.0,Congestive cardiomyopathy,16790834,3
0,22.0,Feeling hot,16790845,1
1,22.0,Oxygen saturation decreased,16790845,1
2,22.0,Dyspnoea,16790845,1
0,22.1,Disease progression,16790849,
0,22.0,Osteonecrosis of jaw,16790857,3
0,22.0,Depression suicidal,16790865,3
1,22.0,Disturbance in attention,16790865,6
2,22.0,Product substitution issue,16790865,6
3,22.0,Cognitive disorder,16790865,1
0,22.0,Off label use,16790880,6
1,22.0,Product use issue,16790880,6
2,22.0,Death,16790880,5
0,22.0,Optic nerve disorder,16790898,6
0,22.0,Death,16790921,5
0,22.0,Death,16790932,5
0,22.0,Therapy partial responder,16790942,3
1,22.0,Diarrhoea,16790942,3
2,22.0,Pneumonia,16790942,3
0,22.0,Asthenia,16790954,3
1,22.0,Varices oesophageal,16790954,3
2,22.0,Ascites,16790954,3
3,22.0,Early satiety,16790954,3
4,22.0,Gastrointestinal haemorrhage,16790954,3
0,22.0,Deep vein thrombosis,16790957,6
0,22.0,Death,16790959,5
0,22.0,Dermatitis acneiform,16790982,3
1,22.0,Hyporeflexia,16790982,3
2,22.0,Muscle contractions involuntary,16790982,3
3,22.0,Asthenia,16790982,3
4,22.0,Paraesthesia,16790982,3
0,22.0,Rash,16790994,6
1,22.0,Acne,16790994,6
2,22.0,Diarrhoea,16790994,6
0,22.1,Pain in extremity,16791014,3
1,22.1,Hypertension,16791014,2
2,22.1,Blood pressure increased,16791014,2
3,22.1,Acne,16791014,3
4,22.1,Fatigue,16791014,3
5,22.1,Cough,16791014,3
6,22.1,Seasonal allergy,16791014,3
7,22.1,Dry mouth,16791014,3
8,22.1,Dry eye,16791014,3
9,22.1,Dehydration,16791014,3
10,22.1,Eye infection,16791014,2
11,22.1,Nausea,16791014,1
12,22.1,Product dose omission,16791014,3
13,22.1,Palmar-plantar erythrodysaesthesia syndrome,16791014,2
14,22.1,Diarrhoea,16791014,2
15,22.1,Decreased appetite,16791014,3
0,22.0,Ileus,16791038,5
0,22.0,Vomiting,16791056,2
1,22.0,Large intestine infection,16791056,2
2,22.0,Diarrhoea,16791056,2
3,22.0,Decreased appetite,16791056,2
0,22.0,Vitreous detachment,16791058,1
0,22.0,Lipase increased,16791082,1
0,22.0,Implantable defibrillator insertion,16791105,6
1,22.0,Thirst,16791105,6
2,22.0,Fatigue,16791105,1
3,22.0,Bone pain,16791105,6
4,22.0,Dry skin,16791105,6
5,22.0,Nausea,16791105,1
6,22.0,Cardiac operation,16791105,6
7,22.0,Headache,16791105,6
8,22.0,Diarrhoea,16791105,3
0,22.0,Off label use,16791106,6
1,22.0,Death,16791106,5
2,22.0,Gait disturbance,16791106,6
3,22.0,Pain,16791106,6
4,22.0,Asthenia,16791106,6
5,22.0,Malaise,16791106,3
6,22.0,Fatigue,16791106,6
0,22.0,Death,16791107,5
0,22.0,Bronchospasm,16791142,1
1,22.0,Hypertension,16791142,1
2,22.0,Malaise,16791142,1
3,22.0,Dyspnoea,16791142,1
4,22.0,Tachycardia,16791142,1
5,22.0,Hypersensitivity,16791142,1
6,22.0,Erythema,16791142,1
0,22.0,Hypoxia,16791144,1
1,22.0,Erythema,16791144,1
2,22.0,Hypotension,16791144,1
3,22.0,Hypersensitivity,16791144,1
4,22.0,Malaise,16791144,1
0,22.0,Dyspnoea,16791145,1
1,22.0,Chest discomfort,16791145,1
2,22.0,Hypersensitivity,16791145,1
3,22.0,Anxiety,16791145,1
0,22.1,Cerebrovascular accident,16791165,3
1,22.1,Vomiting,16791165,6
2,22.1,Seizure,16791165,3
3,22.1,Gait inability,16791165,3
4,22.1,Mood altered,16791165,6
0,22.0,Cytopenia,16791173,6
0,22.1,Death,16791174,
0,22.0,Immune thrombocytopenic purpura,16791186,5
1,22.0,Pulmonary embolism,16791186,5
2,22.0,Thrombocytopenia,16791186,5
0,22.0,Sepsis,16791249,5
1,22.0,Pulmonary haemorrhage,16791249,5
2,22.0,Haemothorax,16791249,5
3,22.0,Respiratory failure,16791249,5
4,22.0,Sinus tachycardia,16791249,6
5,22.0,Facial pain,16791249,6
6,22.0,Hyperhidrosis,16791249,6
7,22.0,Large intestinal haemorrhage,16791249,6
8,22.0,Duodenal ulcer,16791249,6
9,22.0,Gastrointestinal pain,16791249,6
10,22.0,Mucosal infection,16791249,6
11,22.0,Upper respiratory tract infection,16791249,6
12,22.0,Hip fracture,16791249,6
13,22.0,Alanine aminotransferase increased,16791249,6
14,22.0,Lymphocyte count decreased,16791249,6
15,22.0,Platelet count decreased,16791249,6
16,22.0,Dizziness,16791249,6
17,22.0,Encephalopathy,16791249,6
18,22.0,Posterior reversible encephalopathy syndrome,16791249,6
19,22.0,Oropharyngeal pain,16791249,6
20,22.0,Hallucination,16791249,6
21,22.0,Sudden death,16791249,5
22,22.0,Large intestine perforation,16791249,5
23,22.0,Gastric haemorrhage,16791249,5
24,22.0,Embolism,16791249,5
25,22.0,Obstruction gastric,16791249,5
26,22.0,Atrial fibrillation,16791249,6
27,22.0,Pyrexia,16791249,6
28,22.0,Infusion site extravasation,16791249,6
29,22.0,Rash maculo-papular,16791249,6
30,22.0,Abdominal pain,16791249,6
31,22.0,Upper gastrointestinal haemorrhage,16791249,6
32,22.0,Enteritis infectious,16791249,6
33,22.0,Enterocolitis infectious,16791249,6
34,22.0,Fall,16791249,6
35,22.0,Vascular access complication,16791249,6
36,22.0,Troponin I increased,16791249,6
37,22.0,Blood creatinine increased,16791249,6
38,22.0,Dehydration,16791249,6
39,22.0,Hypocalcaemia,16791249,6
40,22.0,Myalgia,16791249,6
41,22.0,Syncope,16791249,6
42,22.0,Respiratory failure,16791249,6
43,22.0,Proteinuria,16791249,6
44,22.0,Pulmonary hypertension,16791249,6
45,22.0,Fatigue,16791249,5
46,22.0,Dyspnoea,16791249,5
47,22.0,Anaemia,16791249,6
48,22.0,Left ventricular dysfunction,16791249,6
49,22.0,Infusion related reaction,16791249,6
50,22.0,Abdominal distension,16791249,6
51,22.0,Colitis,16791249,6
52,22.0,Diarrhoea,16791249,6
53,22.0,Oesophageal perforation,16791249,6
54,22.0,Lower gastrointestinal haemorrhage,16791249,6
55,22.0,Ejection fraction decreased,16791249,6
56,22.0,Weight increased,16791249,6
57,22.0,White blood cell count decreased,16791249,6
58,22.0,Decreased appetite,16791249,6
59,22.0,Hypophosphataemia,16791249,6
60,22.0,Bone pain,16791249,6
61,22.0,Delirium,16791249,6
62,22.0,Pulmonary oedema,16791249,6
63,22.0,Haematuria,16791249,6
64,22.0,Lymph gland infection,16791249,6
65,22.0,Febrile neutropenia,16791249,6
66,22.0,Duodenal perforation,16791249,6
67,22.0,Oesophagitis,16791249,6
68,22.0,Hypersensitivity,16791249,6
69,22.0,Anorectal infection,16791249,6
70,22.0,Oesophageal infection,16791249,6
71,22.0,Skin infection,16791249,6
72,22.0,Aspartate aminotransferase increased,16791249,6
73,22.0,Weight decreased,16791249,6
74,22.0,Musculoskeletal chest pain,16791249,6
75,22.0,Muscular weakness,16791249,6
76,22.0,Confusional state,16791249,6
77,22.0,Depression,16791249,6
78,22.0,Epistaxis,16791249,6
79,22.0,Hypotension,16791249,6
80,22.0,Alopecia,16791249,6
81,22.0,Gastric ulcer,16791249,6
82,22.0,Abdominal pain upper,16791249,6
83,22.0,Paraesthesia,16791249,6
84,22.0,International normalised ratio increased,16791249,6
85,22.0,Cardiac arrest,16791249,5
86,22.0,Cardiac failure,16791249,5
87,22.0,Lung infection,16791249,5
88,22.0,Myocardial infarction,16791249,6
89,22.0,Chills,16791249,6
90,22.0,Face oedema,16791249,6
91,22.0,Dermatitis acneiform,16791249,6
92,22.0,Dysphagia,16791249,6
93,22.0,Oesophageal fistula,16791249,6
94,22.0,Small intestinal obstruction,16791249,6
95,22.0,Device related infection,16791249,6
96,22.0,Troponin T increased,16791249,6
97,22.0,Hyperkalaemia,16791249,6
98,22.0,Hypoalbuminaemia,16791249,6
99,22.0,Back pain,16791249,6
100,22.0,Memory impairment,16791249,6
101,22.0,Neoplasm,16791249,6
102,22.0,Insomnia,16791249,6
103,22.0,Haemothorax,16791249,6
104,22.0,Pancreatitis,16791249,6
105,22.0,Proctitis,16791249,6
106,22.0,Bronchopleural fistula,16791249,6
107,22.0,Menstruation irregular,16791249,6
108,22.0,Hypermagnesaemia,16791249,6
109,22.0,Death,16791249,5
110,22.0,Acute coronary syndrome,16791249,6
111,22.0,Pericardial effusion,16791249,6
112,22.0,Oedema peripheral,16791249,6
113,22.0,Pain,16791249,6
114,22.0,Small intestinal perforation,16791249,6
115,22.0,Hyperglycaemia,16791249,6
116,22.0,Headache,16791249,6
117,22.0,Pneumonitis,16791249,6
118,22.0,Embolism,16791249,6
119,22.0,Neuralgia,16791249,6
120,22.0,Flank pain,16791249,6
121,22.0,Ataxia,16791249,6
122,22.0,Gastric perforation,16791249,5
123,22.0,Non-cardiac chest pain,16791249,6
124,22.0,Constipation,16791249,6
125,22.0,Stomatitis,16791249,6
126,22.0,Nausea,16791249,6
127,22.0,Anal fistula,16791249,6
128,22.0,Pelvic infection,16791249,6
129,22.0,Hypokalaemia,16791249,6
130,22.0,Hypomagnesaemia,16791249,6
131,22.0,Pain in extremity,16791249,6
132,22.0,Peripheral motor neuropathy,16791249,6
133,22.0,Aspiration,16791249,6
134,22.0,Pneumothorax,16791249,6
135,22.0,Hypertension,16791249,6
136,22.0,Intestinal ischaemia,16791249,6
137,22.0,Influenza like illness,16791249,6
138,22.0,Osteonecrosis,16791249,6
139,22.0,Angina pectoris,16791249,6
140,22.0,Cardiac disorder,16791249,6
141,22.0,Gait disturbance,16791249,6
142,22.0,Hypothermia,16791249,6
143,22.0,Gastritis,16791249,6
144,22.0,Vomiting,16791249,6
145,22.0,Anaphylactic reaction,16791249,6
146,22.0,Abdominal infection,16791249,6
147,22.0,Urinary tract infection,16791249,6
148,22.0,Neutrophil count decreased,16791249,6
149,22.0,Hyponatraemia,16791249,6
150,22.0,Arthralgia,16791249,6
151,22.0,Cognitive disorder,16791249,6
152,22.0,Disturbance in attention,16791249,6
153,22.0,Peripheral sensory neuropathy,16791249,6
154,22.0,Hypoxia,16791249,6
155,22.0,Pleural effusion,16791249,6
156,22.0,Wound dehiscence,16791249,6
157,22.0,Cough,16791249,6
158,22.0,Peripheral ischaemia,16791249,6
0,22.0,Death,16791333,5
0,22.0,Pancytopenia,16791336,1
0,22.0,Urinary retention,16791364,4
0,22.0,Drug ineffective,16791374,6
1,22.0,Renal impairment,16791374,6
2,22.0,Rhabdomyolysis,16791374,1
0,22.0,Cytopenia,16791379,6
0,22.0,Drug-induced liver injury,16791411,1
0,22.1,Melaena,16791445,6
1,22.1,Nausea,16791445,6
2,22.1,Muscular weakness,16791445,6
3,22.1,Decreased appetite,16791445,2
4,22.1,Flatulence,16791445,3
5,22.1,Retching,16791445,6
6,22.1,Product dose omission,16791445,6
7,22.1,Loss of personal independence in daily activities,16791445,1
8,22.1,Asthenia,16791445,6
9,22.1,Vomiting,16791445,6
0,22.0,Febrile neutropenia,16791461,5
0,22.0,Tongue neoplasm malignant stage unspecified,16791469,3
1,22.0,Lip and/or oral cavity cancer,16791469,3
0,22.0,Renal failure,16791473,1
1,22.0,Anaemia,16791473,1
0,22.0,Type 2 diabetes mellitus,16791475,4
0,22.0,Anaemia,16791476,1
1,22.0,Renal failure,16791476,3
0,22.0,Hyponatraemia,16791483,3
1,22.0,Asthenia,16791483,1
2,22.0,Vomiting,16791483,1
0,22.0,Bone marrow failure,16791499,1
0,22.0,Nausea,16791512,3
1,22.0,Balance disorder,16791512,3
2,22.0,Oral discomfort,16791512,3
3,22.0,Asthenia,16791512,3
4,22.0,Fatigue,16791512,3
0,22.0,Pneumonia,16791516,6
1,22.0,Thrombocytopenia,16791516,6
2,22.0,Renal failure,16791516,6
3,22.0,Proteinuria,16791516,6
4,22.0,Neutropenia,16791516,6
5,22.0,Anaemia,16791516,6
0,22.0,Anaemia,16791565,3
1,22.0,Thrombocytopenia,16791565,3
2,22.0,Neutropenia,16791565,3
0,22.0,Mucosal necrosis,16791589,6
1,22.0,Neutrophil count decreased,16791589,6
0,22.0,Dehydration,16791590,1
0,22.1,Sudden death,16791607,5
0,22.1,Disease progression,16791653,
0,22.1,Disease progression,16791656,
0,22.1,Full blood count decreased,16791659,
0,22.1,Disease progression,16791689,
0,22.0,Constipation,16791692,3
1,22.0,Feeling of body temperature change,16791692,3
2,22.0,Diarrhoea,16791692,3
3,22.0,Gait disturbance,16791692,3
4,22.0,Decreased appetite,16791692,3
5,22.0,Weight decreased,16791692,3
6,22.0,Malaise,16791692,3
7,22.0,Tremor,16791692,3
0,22.1,Disease progression,16791708,
0,22.1,Disease progression,16791732,
0,22.1,Disease progression,16791741,
0,22.1,Epilepsy,16791765,1
0,22.0,Hypokalaemia,16791783,6
0,22.0,Drug resistance,16791794,6
1,22.0,Malignant neoplasm progression,16791794,6
0,22.0,Dehydration,16791809,2
1,22.0,Nausea,16791809,2
2,22.0,Weight decreased,16791809,3
3,22.0,Vomiting,16791809,2
4,22.0,Diarrhoea,16791809,2
0,22.0,Off label use,16791812,6
1,22.0,Nausea,16791812,3
2,22.0,Decreased appetite,16791812,3
3,22.0,Blood phosphorus decreased,16791812,1
4,22.0,Product use issue,16791812,6
5,22.0,Diarrhoea,16791812,1
6,22.0,Vomiting,16791812,1
0,22.0,Tachycardia,16791830,2
1,22.0,Groin pain,16791830,2
2,22.0,Hot flush,16791830,2
3,22.0,Malaise,16791830,2
4,22.0,Hyperhidrosis,16791830,2
0,22.0,Fatigue,16791840,6
1,22.0,Hot flush,16791840,6
2,22.0,Headache,16791840,6
0,22.0,Speech disorder,16791846,6
0,22.0,Hypoacusis,16791855,6
1,22.0,Off label use,16791855,6
2,22.0,Product use in unapproved indication,16791855,6
0,22.0,Disease progression,16791872,5
1,22.0,Breast cancer,16791872,5
0,22.0,Myasthenia gravis,16791890,2
1,22.0,Myopathy,16791890,2
0,22.0,Metastases to central nervous system,16791918,6
1,22.0,Death,16791918,5
2,22.0,Malignant neoplasm progression,16791918,6
0,22.1,Pulmonary embolism,16791928,1
0,22.0,Electrolyte imbalance,16791933,2
1,22.0,Respiratory failure,16791933,1
2,22.0,Lung infection,16791933,2
3,22.0,Hypoproteinaemia,16791933,2
4,22.0,Bone marrow failure,16791933,1
0,22.1,Complication associated with device,16791972,1
0,22.0,Kidney infection,16791974,6
0,22.1,Sleep disorder,16791975,6
1,22.1,Stomatitis,16791975,1
2,22.1,Urinary tract infection,16791975,1
3,22.1,Anaemia,16791975,6
4,22.1,Pharyngitis,16791975,1
5,22.1,Blood creatinine increased,16791975,2
6,22.1,Thrombocytopenia,16791975,2
0,22.0,Bone marrow failure,16791981,1
0,22.0,Glioma,16792004,5
1,22.0,Product use in unapproved indication,16792004,6
2,22.0,Product use issue,16792004,6
3,22.0,Second primary malignancy,16792004,5
0,22.1,Lymphoma,16792019,6
1,22.1,Pneumonia,16792019,6
2,22.1,Death,16792019,5
0,22.1,C-reactive protein increased,16792032,3
1,22.1,Nausea,16792032,6
2,22.1,Oedema peripheral,16792032,6
3,22.1,Pelvic fluid collection,16792032,6
4,22.1,Visual impairment,16792032,6
5,22.1,Malignant neoplasm progression,16792032,5
6,22.1,Breast cancer metastatic,16792032,5
7,22.1,Calcium deficiency,16792032,5
8,22.1,Blood uric acid increased,16792032,6
9,22.1,Aspartate aminotransferase increased,16792032,6
10,22.1,Cholelithiasis,16792032,6
11,22.1,Vomiting,16792032,1
12,22.1,Hepatomegaly,16792032,6
13,22.1,Anaemia,16792032,2
14,22.1,Hyperbilirubinaemia,16792032,6
15,22.1,Palpitations,16792032,2
16,22.1,Abdominal pain upper,16792032,2
17,22.1,Gamma-glutamyltransferase increased,16792032,3
18,22.1,Alanine aminotransferase increased,16792032,6
19,22.1,Asthenia,16792032,5
20,22.1,Eastern Cooperative Oncology Group performance status worsened,16792032,6
21,22.1,Blood potassium increased,16792032,6
22,22.1,Activated partial thromboplastin time prolonged,16792032,6
23,22.1,Fatigue,16792032,5
24,22.1,Blood calcium decreased,16792032,6
25,22.1,Blood creatinine increased,16792032,6
26,22.1,Epistaxis,16792032,3
0,22.0,Anaphylactic reaction,16792054,1
0,22.0,Neutropenia,16792056,2
0,22.1,Bone marrow failure,16792057,1
0,22.1,Pruritus,16792089,2
1,22.1,Neuropathy peripheral,16792089,1
2,22.1,Off label use,16792089,
3,22.1,Dyschezia,16792089,3
0,22.1,Malnutrition,16792094,6
1,22.1,Gastrointestinal disorder,16792094,6
2,22.1,Malignant neoplasm progression,16792094,6
3,22.1,Drug intolerance,16792094,6
4,22.1,General physical health deterioration,16792094,6
5,22.1,Cachexia,16792094,6
6,22.1,Behaviour disorder,16792094,6
7,22.1,Dehydration,16792094,6
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,16792095,3
0,22.0,Nausea,16792159,1
1,22.0,Product use in unapproved indication,16792159,6
2,22.0,Diarrhoea,16792159,1
3,22.0,Balance disorder,16792159,6
0,22.0,Weight decreased,16792176,6
1,22.0,Off label use,16792176,6
0,22.0,Anaphylactic shock,16792186,6
0,22.1,Acidosis,16792205,5
1,22.1,Gastrointestinal perforation,16792205,5
2,22.1,Colon cancer,16792205,5
3,22.1,Disseminated intravascular coagulation,16792205,5
0,22.0,Off label use,16792265,6
1,22.0,Intentional product use issue,16792265,6
2,22.0,Chills,16792265,6
3,22.0,Fatigue,16792265,6
0,22.0,Arthritis,16792277,6
1,22.0,Ovarian cyst,16792277,1
2,22.0,Spinal column injury,16792277,6
3,22.0,Arthropathy,16792277,6
4,22.0,Tumour haemorrhage,16792277,6
5,22.0,Scar,16792277,6
0,22.0,Stomatitis,16792281,1
1,22.0,Bone marrow failure,16792281,1
2,22.0,Toxicity to various agents,16792281,1
3,22.0,Hypoperfusion,16792281,1
4,22.0,Diarrhoea haemorrhagic,16792281,1
5,22.0,Neutropenia,16792281,1
6,22.0,Overdose,16792281,1
7,22.0,Ischaemia,16792281,1
8,22.0,Gastrointestinal mucosal exfoliation,16792281,6
9,22.0,Colitis,16792281,1
10,22.0,Hypovolaemia,16792281,1
0,22.0,Left ventricular dysfunction,16792283,2
1,22.0,Congestive cardiomyopathy,16792283,6
0,22.0,Parophthalmia,16792292,1
1,22.0,Iridocyclitis,16792292,1
2,22.0,Scleritis,16792292,1
0,22.0,Ventricular tachycardia,16792299,5
1,22.0,Myocarditis,16792299,6
2,22.0,Interstitial lung disease,16792299,6
0,22.0,Bone marrow failure,16792312,6
1,22.0,Skin reaction,16792312,6
2,22.0,Neurotoxicity,16792312,6
3,22.0,Gastrointestinal disorder,16792312,6
4,22.0,Appendicitis noninfective,16792312,6
5,22.0,Hepatic function abnormal,16792312,6
6,22.0,Mucosal disorder,16792312,6
0,22.0,Fatigue,16792317,1
1,22.0,Hyperglycaemia,16792317,4
